Abortion

This brief outlines the intersection of federal policy regarding dispensing medication abortion with state laws regulating the provision of abortion services and mifepristone dispensing via telehealth and considers the implications of the recent FDA change in different states.

With the country waiting on the Supreme Court’s decision on Dobbs v. Jackson Women’s Health Organization, the case that could overturn Roe v. Wade, many are looking towards telehealth as an alternative to expand access to medication abortion. A new KFF issue brief explains the newly revised Food and Drug…

This brief examines abortion laws in countries that received certain U.S. foreign assistance to better understand the implications of the Helms Amendment (which prohibits the use of foreign assistance to pay for the performance of abortion as a method of family planning or to motivate or coerce any person to practice abortion) for abortion access globally.

If Roe v. Wade is overturned, many states will quickly move to restrict or ban abortions. People seeking an abortion who live in those states may be able to access medication abortion via telehealth if their state does not restrict it and if they are within the first 10 weeks of pregnancy.

In this video, KFF Associate Director for Women’s Health Policy Laurie Sobel describes how a ruling overturning Roe could affect abortion access in the United States.

The Supreme Court, Congress, and state policymakers are currently debating issues that are central to women’s health and well-being. Watch the KFF Women’s Health Policy team web briefing to learn more about the status and implications of these debates, from abortion to paid leave.

On December 1, the Supreme Court will hear their first abortion case that could overturn Roe v. Wade, with a solid conservative majority. The case, Thomas E. Dobbs, State Health Officer of the Mississippi Department of Health v. Jackson Women’s Health Organization, involves a Mississippi law banning nearly all abortions…

This issue brief provides background on the legal challenges to the Mississippi law in the context of the Supreme Court abortion precedents, addresses the intersections with the litigation that has arisen from S.B. 8, the Texas 6-week abortion ban, and explains the potential outcomes and how they could impact access to abortion around the country.

This infographic highlights data and policies regarding the availability and effectiveness of medication abortion in the United States. Medication abortion accounts for more than half (54%) of all abortions before nine weeks gestation in the U.S.  

A KFF brief explains June Medical Services LLC v. Russo, a challenge to a Louisiana abortion regulation that will be heard at the Supreme Court on March 4, 2020.